Teva Pharmaceuticals USA: LOSARTAN POTASSIUM TABLETS, USP 50 mg, Bulk
Recall reason: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.. Recalled by Teva Pharmaceuticals USA. Distribution: Bulk product was distributed to one re-packager in California.. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lots 1195625A, 1195624A, 1195623A, exp. date 03/2020. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report